Search clinical trials for: Xeomin®

Total 13772 results

Multiple Sclerosis Center of Northeastern New York
Merz North America, Inc.

Completed

Safety of Xeomin for Lower Limb Spasticity in Multiple Sclerosis Patients

Multiple Sclerosis | Muscle Spasticity

United States
Merz North America, Inc.

Recruiting

A Study of NT 201 in the Treatment of Enlarged Pores and Excessive Sebum Production in the Face (LESS)

Sebum Production | Enlarged Pores

United States
HaEmek Medical Center, Israel
Holy Family Hospital, Nazareth, Israel

Recruiting

Skin Glues Compared to Running Sutures for Perineal Skin Repair After Vaginal Delivery. A Randomized Controlled Trial

Perineal Tear

Israel
Naval Medical Center Camp Lejeune

Recruiting

BOTOX® vs. XEOMIN® for Chronic Migraine

Chronic Migraine

United States
Medical College of Wisconsin

Recruiting

Botulinum Toxin A for the Treatment of Chemotherapy Induced Peripheral Neuropathy

Peripheral Neuropathy Due to Chemotherapy

United States
Icahn School of Medicine at Mount Sinai
Merz North America, Inc.

Completed

Incobotulinum Toxin A (Xeomin®) As A Treatment For Focal Task-Specific Dystonia Of The Musician's Hand

Dystonia

United States
Cairo University

Unknown

Evaluating Lip Repositioning for the Treatment of Excess Gingival Display With and Without Pretreatment With Botox

Gingival Overgrowth
Merz Aesthetics GmbH

Completed

A Study of NT 201 Doses in the Treatment of Platysma Prominence (PAOLA)

Platysma Prominence

United States
Zel Skin and Laser Specialists
Merz Aesthetics Inc.

Active, not recruiting

Use of Botulinum Toxin in the Treatment of Androgenic Alopecia

Androgenetic Alopecia

United States
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Completed

Levocarnitine in Treating Fatigue in Cancer Patients

Fatigue | Unspecified Adult Solid Tumor, Protocol Specific

United States
Beth Israel Deaconess Medical Center
Merz Pharmaceuticals

Withdrawn

Incobotulinum Toxin A for Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS) (Xeomin)

Parkinson Disease | Amyotrophic Lateral Sclerosis

United States
Universidad Autonoma de San Luis Potosí

Completed

Comparison of Remineralisation Efficacy of MI PASTE Plus® and REMIN PRO® for White Spot Lesions in Primary Teeth

White Spot Lesion

Mexico
Northwestern University

Active, not recruiting

A Pilot Study Testing Onabotulinum Toxin A Versus Incobotulinum Toxin A Injections for Facial Wrinkles

Wrinkles

United States
Beth Israel Deaconess Medical Center

Completed

Incobotulinum Toxin A (Xeomin®) for Troublesome Sialorrhea in Parkinson's Disease (PD)/Parkinsonism

Sialorrhea

United States
Merz Pharmaceuticals GmbH

Completed

Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Abnormal Contraction or Twitch of the Eyelid

Bilateral Blepharospasm (BEB)

Greece, Malaysia, Sri Lanka
Merz North America, Inc.

Terminated

Longitudinal Evaluation and Real-world Evidence of NT201

Glabellar Frown Lines and Canthal Lines and/or Horizontal Forehead Lines in the Upper Face

United States
Defymed

Recruiting

Pilot Study Evaluating Safety of ExOlin® in Patients With Poorly Controlled Type 1 Diabetes (Pilot'Ex)

Type 1 Diabetes | Type 1 Diabetes Mellitus With Hypoglycemia

France
Sanofi

Completed

Efficacy and Safety Study of New Ambroxol Hardboiled Lozenges in Acute Pharyngitis (DELICIOUS)

Pharyngitis

South Africa
Wake Forest University Health Sciences
Merz Pharmaceuticals GmbH

Recruiting

Xeomin® and Gait Related Mobility After Stroke

Stroke

United States
The Maas Clinic
Merz North America, Inc.

Unknown

Comparison of Escalating Doses of IncobotulinumtoxinA (Xeomin®) in the Treatment of Glabellar Rhytids

Skin Aging | Elastosis Senilis

United States
Allergan

Completed

An Observational Retrospective Study to Evaluate Treatment Patterns of Botulinum Toxin Type A

Facial Rhytides

Argentina
Dominik Ettlin
Merz Pharmaceuticals

Not yet recruiting

Bruxism Xeomin® Intervention Trial (BRUX-XIT)

Sleep Bruxism, Adult

Switzerland
Huons Biopharma

Not yet recruiting

To Evaluate HU-045 in the Treatment of Glabellar Lines(Phase III)

Glabellar Lines
Cairo University

Unknown

Evaluation of Remin Pro Forte Versus Remin Pro on Treatment of White Spot Lesions Post Orthodontic Treatment

White Spot Lesion
Ipsen

Completed

A Comparative Study to Evaluate the Effects and Mechanism of Action of Dysport®, Botox® and Xeomin® in the Extensor Digitorum Brevis Model in Healthy Adult Male Participants

Healthy Participants

United Kingdom
Huons Co., Ltd.

Completed

Phase 2 of HU-045 in Glabellar Lines

Glabellar Lines

Korea, Republic of
Allergan

Completed

Comparison of Two Botulinum Type A Products in the Treatment of Blepharospasm

Blepharospasm

Germany
Innovaderm Research Inc.
Merz Pharmaceuticals GmbH

Completed

Treatment of Notalgia Paresthetica With Xeomin

Notalgia Paresthetica

Canada
Merz North America, Inc.
Registrat-Mapi

Completed

Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States (XCiDaBLE)

Cervical Dystonia | Blepharospasm

United States
ATGC Co., Ltd.

Recruiting

Study to Compare the Efficacy and Safety of ATGC-110 (Botulinum Toxin) With Xeomin® for the Treatment of Moderate to Severe Glabellar Frown Lines

Glabellar Frown Lines

Korea, Republic of
Centre Hospitalier Universitaire de Nīmes

Terminated

Evaluation of Three Types of Injection for the Treatment of Lateral Epicondylalgia (LET)

Tennis Elbow | Epicondylitis, Lateral Humeral

France
Merz Pharmaceuticals GmbH

Completed

NT 201 (Xeomin®/Bocouture®) in Comparison With Clostridium Botulinum Toxin Type A in the Treatment of Glabellar Frown Lines (Head2Head)

Glabellar Frown Lines

United Kingdom, Germany, Austria
Assistance Publique - Hôpitaux de Paris
Merz Pharmaceuticals GmbH

Recruiting

DEgenerative ROtator Cuff Disease and Botulinum TOXin (DEROTOX)

Degenerative Rotator Cuff Disease

France
The University of Texas Medical Branch, Galveston

Active, not recruiting

Acute Porphyria Biomarkers for Disease Activity

Hereditary Coproporphyria | Acute Intermittent Porphyria | Variegate Porphyria

United States
Mayo Clinic
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Recordati...

Completed

A Pilot Study of Hemin Therapy for Gastroparesis (Diabetes Mellitus)

Diabetes Mellitus | Gastroparesis

United States
Merz Pharmaceuticals GmbH

Completed

IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Cervical Dystonia

Cervical Dystonia

United States
Assistance Publique - Hôpitaux de Paris
Ministry of Health, France; Merz Pharmaceuticals

Recruiting

Prevention Atrial Fibrillation by BOTulinum Toxin Injections (BOTAF) (BOTAF)

Cardiac Surgery

France
Assistance Publique - Hôpitaux de Paris

Active, not recruiting

Efficacy of Intracavernosal as add-on Therapy to Sildenafil 100 mg on Demand Compared to Sildenafil 100 mg on Demand for the Treatment of Erectile Dysfunction (ED) Not Sufficiently Responsive to Standard Therapy With Phosphodiesterase Type 5 Inhibitors (MENOX)

Erectile Dysfunction

France
Merz North America, Inc.

Completed

The Treatment of Glabellar Frown Lines

Glabellar Frown Lines

United States
Biolab Sanus Farmaceutica

Completed

Clinical Trial to Assess Efficacy, Safety and Tolerability of Botulinum Toxin A (Xeomin®) in Treatment of Expression Wrinkles in the Upper Third of the Face (XEO-001/07)

Skin Aging

Brazil
Washington University School of Medicine
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

To Define the Role of GLP-1 for Improving Glucose Homeostasis in Humans Following Gastric Bypass Surgery

Roux-en-Y Gastric Bypass | Bariatric Surgery | Vertical Sleeve Gastrectomy | Gastric Banding | Bypass, Gastric

United States
Fundacion Clinic per a la Recerca Biomédica
Fundacion iSYS, internet, salud y sociedad

Completed

Evaluation of the Impact of a Multidimensional ICT Intervention on the Quality of Life of Breast Cancer Survivors

Quality of Life | Breast Cancer | Breast Neoplasms | Survivorship

Spain
Merz Pharmaceuticals GmbH
Merz North America, Inc.

Completed

Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dystonia Flex

Cervical Dystonia

United States
YMD Eye and Face

Completed

Split-Face Prospective Study Comparing Botox to Xeomin for the Treatment of Facial Wrinkles

Facial Wrinkles

United States
Al-Azhar University

Completed

Combined Application of Diode Laser and Different Remineralizing Agents on White Spot Lesions (Whitespot)

White Spot Lesion of Tooth

Egypt
Instituto Portugues da Face

Completed

Outcomes of Bilateral Temporomandibular Joint Arthroscopy and the Role of a Second Intervention - Timings and Results

Bilateral Temporomandibular Joint Disorder
Washington University School of Medicine
American Diabetes Association

Withdrawn

Effects of Xenin-25 on Insulin Secretion and Gastric Emptying in Humans With and Without a Complete Truncal Vagotomy

Does the Vagus Nerve Mediate the Effects of Xenin-25

United States
Mayo Clinic

Completed

Hemin in Healthy Subjects

Healthy Volunteers

United States
Washington University School of Medicine
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Study of the Effects of Xenin-25 in Humans With and Without Type 2 Diabetes Mellitus

Diabetes

United States
Washington University School of Medicine
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Xenin-25: Novel Regulator of Insulin Secretion and Beta-cell Function

Type 2 Diabetes Mellitus

United States

Search clinical trials for: Xeomin®

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hong Kong

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations